{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:55:36Z","timestamp":1791114936522,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,1,7]],"date-time":"2008-01-07T00:00:00Z","timestamp":1199664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,1,7]],"date-time":"2008-01-07T00:00:00Z","timestamp":1199664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1038\/sj.bmt.1705955","type":"journal-article","created":{"date-parts":[[2008,1,7]],"date-time":"2008-01-07T11:54:17Z","timestamp":1199706857000},"page":"651-658","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants"],"prefix":"10.1038","volume":"41","author":[{"given":"R","family":"Hoyt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D S","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A W","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"MacGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D J","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Szer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A P","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,7]]},"reference":[{"key":"BF1705955_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.seminhematol.2005.09.007","volume":"43","author":"NJ Chao","year":"2006","unstructured":"Chao NJ, Chen BJ . Prophylaxis and treatment of acute graft versus host disease. Semin Hematol 2006; 43: 32\u201341.","journal-title":"Semin Hematol"},{"key":"BF1705955_CR2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/sj.bmt.1700710","volume":"19","author":"HM Lazarus","year":"1997","unstructured":"Lazarus HM, Vogelsang GB, Rowe JM . Prevention and treatment of acute graft-versus host-disease: the old and the new. A report from the Eastern Cooperative Oncology group (ECOG). Bone Marrow Transplant 1997; 19: 577\u2013600.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705955_CR3","first-page":"2062","volume":"96","author":"RA Nash","year":"2000","unstructured":"Nash RA, Antin JH, Karanes C, Fay JW, Avalos BR, Yeager AW et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 2000; 96: 2062\u20132068.","journal-title":"Blood"},{"key":"BF1705955_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1056\/NEJM200101183440303","volume":"344","author":"WI Bensinger","year":"2001","unstructured":"Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R et al. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175\u2013181.","journal-title":"N Engl J Med"},{"key":"BF1705955_CR5","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood.V96.7.2391","volume":"96","author":"T Ruutu","year":"2000","unstructured":"Ruutu T, Volin L, Parkkali T, Juvonen E, Elonen E . Cyclosporine, methotrexate and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host-disease in bone marrow transplantation from HLA-identical sibling donors: a prospective randomized study. Blood 2000; 96: 2391\u20132398.","journal-title":"Blood"},{"key":"BF1705955_CR6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1445-5994.1991.tb01406.x","volume":"21","author":"K Atkinson","year":"1991","unstructured":"Atkinson K, Biggs J, Concannon A, Dodds A, Young S, Wilson F et al. A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy. Aust NZ J Med 1991; 21: 850\u2013856.","journal-title":"Aust NZ J Med"},{"key":"BF1705955_CR7","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1056\/NEJM199310213291703","volume":"329","author":"NJ Chao","year":"1993","unstructured":"Chao NJ, Schmidt GM, Niland JC, Amylon MD, Dagis AC, Long GD et al. Cyclosporine, methotrexate and prednisone compared with cyclosporine and prednisolone for prophylaxis of acute graft-versus-host disease. N Engl J Med 1993; 329: 1225\u20131230.","journal-title":"N Engl J Med"},{"key":"BF1705955_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S1083-8791(00)70007-3","volume":"6","author":"NJ Chao","year":"2000","unstructured":"Chao NJ, Snyder DS, Jain M, Wong RM, Niland JC, Negrin RS et al. Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial. Biol Blood Marrow Transplant 2000; 6: 254\u2013261.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705955_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1083-8791(99)70003-0","volume":"5","author":"M Ross","year":"1999","unstructured":"Ross M, Schmidt GM, Niland JC, Amylon MD, Dagis AC, Long GD et al. Cyclosporine, methotrexate and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs-host disease: effect on chronic graft-vs-host disease and long-term survival. Biol Blood Marrow Transplant 1999; 5: 285\u2013291.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705955_CR10","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood.V76.5.1037.1037","volume":"76","author":"R Storb","year":"1990","unstructured":"Storb R, Pepe M, Anasetti C, Appelbaum FR, Beatty P, Doney K et al. What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants? Blood 1990; 76: 1037\u20131045.","journal-title":"Blood"},{"key":"BF1705955_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/sj.bmt.1703085","volume":"28","author":"I Anc\u00edn","year":"2001","unstructured":"Anc\u00edn I, Ferr\u00e1 C, Gallardo D, Peris J, Berlanga J, Gonzalez JR et al. Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT? Bone Marrow Transplant 2001; 28: 39\u201345.","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"BF1705955_CR12","first-page":"2","volume":"12","author":"VM Funke","year":"2006","unstructured":"Funke VM, Setubal DC, Ruiz J, Lima DH, Bonfim CM, Bitencourt MA et al. Low incidence of acute graft versus host disease and reduced early mortality in CP-CML patients transplanted using CSA, MTX and MP as immunoprophylaxis. Biol Blood Marrow Transplant 2006; 12 (Suppl 1): 2 (abstract 84).","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705955_CR13","first-page":"S1","volume":"91","author":"S Quellmann","year":"2006","unstructured":"Quellmann S, Bohlius J, Huebel K, Schwarzer G, Engert A . Corticosteroids for preventing graft-versus-host disease after myeloablative stem cell transplantation: a comprehensive meta-analysis. Haematologica 2006; 91: S1 (abstract 0302).","journal-title":"Haematologica"},{"key":"BF1705955_CR14","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1182\/blood.V98.6.1739","volume":"98","author":"M Remberger","year":"2001","unstructured":"Remberger M, Ringd\u00e9n O, Blau I-W, Ottinger H, Kremens B, Kiehl MG et al. No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors. Blood 2001; 98: 1739\u20131745.","journal-title":"Blood"},{"key":"BF1705955_CR15","first-page":"3702","volume":"95","author":"RE Champlin","year":"2000","unstructured":"Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood 2000; 95: 3702\u20133709.","journal-title":"Blood"},{"key":"BF1705955_CR16","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1200\/JCO.2005.09.020","volume":"23","author":"Stem Cell Trialists' Collaborative Group","year":"2005","unstructured":"Stem Cell Trialists' Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol 2005; 23: 5074\u20135087.","journal-title":"J Clin Oncol"},{"key":"BF1705955_CR17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1182\/blood-2001-12-0304","volume":"100","author":"N Schmitz","year":"2002","unstructured":"Schmitz N, Beksac M, Hasenclever D, Bacigalupo A, Ruutu T, Nagler A et al. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood 2002; 100: 761\u2013767.","journal-title":"Blood"},{"key":"BF1705955_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1182\/blood-2002-01-0011","volume":"100","author":"MED Flowers","year":"2002","unstructured":"Flowers MED, Parker PM, Johnston LJ, Matos AVB, Storer B, Bensinger WI et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long term follow up of a randomized trial. Blood 2002; 100: 415\u2013419.","journal-title":"Blood"},{"key":"BF1705955_CR19","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.bbmt.2006.12.449","volume":"13","author":"AP Grigg","year":"2007","unstructured":"Grigg AP, Gibson J, Bardy PG, Reynolds J, Shuttleworth P, Koelmeyer RL et al. A prospective multicenter trial of peripheral blood stem cell allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclosphosphamide reduced intensity conditioning. Biol Blood Marrow Transplant 2007; 13: 560\u2013567.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705955_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1083-8791(03)00128-9","volume":"9","author":"DS Ritchie","year":"2003","unstructured":"Ritchie DS, Morton J, Szer J, Roberts AW, Durrant S, Shuttleworth P et al. Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalan. Biol Blood Marrow Transplant 2003; 9: 435\u2013442.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705955_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"10","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 10: 295\u2013304.","journal-title":"Transplantation"},{"key":"BF1705955_CR22","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Soci\u00e9 G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945\u2013955.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705955_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1444-0903.2004.00550.x","volume":"34","author":"J Szer","year":"2004","unstructured":"Szer J, Durrant S, Schwarer AP, Bradstock KF, Gibson J, Arthur C et al. Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation. Intern Med J 2004; 34: 98\u2013101.","journal-title":"Intern Med J"},{"key":"BF1705955_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1086\/323335","volume":"34","author":"S Ascioglu","year":"2002","unstructured":"Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7\u201314.","journal-title":"Clin Infect Dis"},{"key":"BF1705955_CR25","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1210\/jc.2006-0684","volume":"91","author":"AP Grigg","year":"2006","unstructured":"Grigg AP, Shuttleworth P, Reynolds J, Schwarer AP, Szer J, Bradstock K et al. Pamidronate reduces bone loss after allogeneic stem cell transplantation. J Clin Endocrinol Metab 2006; 91: 3835\u20133843.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1705955_CR26","first-page":"401","volume":"15","author":"A Leelasiri","year":"1995","unstructured":"Leelasiri A, Greer JP, Stein RS, Goodman S, Brandt SA, Edwards JR et al. Graft-versus-host disease prophylaxis for matched unrelated donor bone marrow transplantation: comparison between cyclosporine-methotrexate and cyclosporine-methotrexate-methylprednisolone. Bone Marrow Transplant 1995; 15: 401\u2013405.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705955.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705955","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705955.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:49:29Z","timestamp":1648082969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["BF1705955"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705955","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,7]]},"assertion":[{"value":"11 July 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}